
Hamish Philpott
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr Hamish Philpott is a gastroenterologist and early career researcher who has completed a PhD at Monash University related to eosinophilic esophagitis. Dr Philpott received a NHMRC scholarship to support his PhD studies, and since became the Philip Bushell Foundation Research Travel Award recipient for 2016/17, and has additional research funding from the philanthropic organisation for eosinophilic disease (ausEE). He has >40 research publications, most of which relate to eosinophilic gastrointestinal disease. Dr Philpott returned from the University of North Carolina Chapel Hill in June 2017, and has taken up a staff specialist position in Adelaide (Northern Adelaide Local Health Network/University of Adelaide).
-
Education
Date Institution name Country Title Monash University, Melbourne Australia PhD University of Adelaide Australia MBBS -
Research Interests
-
Journals
Year Citation 2025 Philpott, H., Lemberg, D. A., Day, A. S., Rosenbaum, J., Singh, H., Rumore, S., . . . Sharma, A. (2025). Characteristics and management of eosinophilic esophagitis in Australasian children: a decade of experience. Internal Medicine Journal, 55(2), 284-289.
2023 Au, M., Heddle, G., Young, E., Ryan, E., Graf, S., Tee, D., & Philpott, H. (2023). Anti-tumour necrosis factor-induced skin rashes in inflammatory bowel disease: a systematic review and evidence-based management algorithm. Internal Medicine Journal, 53(10), 1854-1865.
Scopus4 WoS1 Europe PMC22023 Thakk, K. P., Philpott, H., Lafata, S., Fowler, M., Keene, S., Iuga, A., & Dellon, E. S. (2023). Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsivePatients with Eosinophilic Esophagitis. Journal of Gastrointestinal and Liver Diseases, 32(1), 15-22.
Scopus6 Europe PMC22023 Kaazan, P., Seow, W., Tan, Z., Logan, H., Philpott, H., Huynh, D., . . . Tse, E. (2023). Deliberate foreign body ingestion in patients with underlying mental illness: A retrospective multicentre study. Australasian Psychiatry, 31(5), 619-624.
Scopus4 Europe PMC32022 Dellon, E. S., Gonsalves, N., Abonia, J. P., Alexander, J. A., Arva, N. C., Atkins, D., . . . Aceves, S. S. (2022). International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clinical Gastroenterology and Hepatology, 20(11), 2474-2484.e3.
Scopus104 WoS26 Europe PMC522022 Young, E., & Philpott, H. (2022). Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management. Digestive Diseases and Sciences, 67(4), 1101-1115.
Scopus8 WoS5 Europe PMC52022 Au, M., Rajagopalan, A., Tee, D., & Philpott, H. (2022). Immune checkpoint inhibitor colitis with concurrent cytomegalovirus reactivation. Internal Medicine Journal, 52(3), 504-505.
Scopus1 Europe PMC12022 Young, E., Rojas Vasquez, L. S., Philpott, H., & Lim, A. (2022). Low FODMAP diet for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews, 2022(8).
2022 Young, E. J., Rajandran, A., Philpott, H. L., Sathananthan, D., Hoile, S. F., & Singh, R. (2022). Mucosal imaging in colon polyps: New advances and what the future may hold. World Journal of Gastroenterology, 28(47), 6632-6661.
Scopus3 Europe PMC12021 Philpott, H., & Dellon, E. S. (2021). Eosinophilic GI Disorders After Transplantation Are a Unique Transient Entity. American Journal of Gastroenterology, 116(7), 1554-1555.
Scopus1 WoS12021 Young, E., Philpott, H., & Singh, R. (2021). Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. World Journal of Gastroenterology, 27(31), 5126-5151.
Scopus40 WoS25 Europe PMC292021 Sharma, A., Eluri, S., Philpott, H., Lemberg, D. A., & Dellon, E. S. (2021). EoE Down Under Is Still EoE: Variability in Provider Practice Patterns in Australia and New Zealand Among Pediatric Gastroenterologists. Digestive Diseases and Sciences, 66(7), 2301-2310.
Scopus5 WoS4 Europe PMC52020 Chan, A., Philpott, H., Lim, A. H., Au, M., Tee, D., Harding, D., . . . Singh, R. (2020). Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 12(11), 43 pages.
2020 Sharma, A., & Philpott, H. (2020). Recognising eosinophilic oesophagitis. Frontline Gastroenterology, 11(1), 3-4.
Scopus12020 Philpott, H., Lee, S. Z., Arrington, A., McGee, S., & Dellon, E. S. (2020). Impact of food challenge on local oesophageal immunophenotype in eosinophilic oesophagitis.. Clinical Mechanisms in Allergic Disease, 50(4), 463-470.
Scopus4 WoS4 Europe PMC12019 Rumore, S., & Philpott, H. (2019). More than just reflux the era of eosinophilic oesophagitis. Medicine Today, 20(5), 49-52. 2019 Philpott, H., Dougherty, M., Torpy, D., & Dellon, E. (2019). Letter: reassuringly normal response to ACTH in children treated with swallowed topical corticosteroids for eosinophilic oesophagitis – authors’ reply. Alimentary Pharmacology and Therapeutics, 49(12), 1539.
2018 Philpott, H., & Dellon, E. (2018). The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?. Journal of Gastroenterology, 53(2), 165-171.
Scopus36 WoS25 Europe PMC212018 Philpott, H., Dougherty, M. K., Reed, C. C., Caldwell, M., Kirk, D., Torpy, D. J., & Dellon, E. S. (2018). Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis. Alimentary Pharmacology and Therapeutics, 47(8), 1071-1078.
Scopus57 WoS37 Europe PMC252018 Ellison, S., & Philpott, H. (2018). A New Paradigm in the Treatment of Eosinophilic Esophagitis: Proton Pump Inhibitors Are Safe, Aim for "Deep Remission". Journal of pediatric gastroenterology and nutrition, 67(2), 146-147.
2018 Sharma, A., & Philpott, H. (2018). Food Bolus Impaction in the Era of Increased EoE Recognition: Push and Pull, Biopsy and Dilate Before It Is Too Late. Digestive Diseases and Sciences, 63(6), 1371-1373.
Scopus3 WoS22018 Philpott, H., & Dellon, E. (2018). Histologic improvement after 6 weeks of dietary elimination for eosinophilic esophagitis may be insufficient to determine efficacy.. Asia Pacific allergy, 8(2), e20.
WoS18 Europe PMC102018 Shahzad, M. A., Harding, D., Ruszkiewicz, A., Tran, E., England, G., & Philpott, H. (2018). Gastrointestinal: Olmesartan-induced enteropathy. Journal of Gastroenterology and Hepatology (Australia), 33(10), 1691.
Scopus4 WoS5 Europe PMC42018 Philpott, H., Dougherty, M. K., & Dellon, E. S. (2018). Letter: screening for adrenal suppression in paediatric inflammatory bowel disease – authors’ reply. Alimentary Pharmacology and Therapeutics, 48(8), 885-886.
2018 Dellon, E. S., Liacouras, C. A., Molina-Infante, J., Furuta, G. T., Spergel, J. M., Zevit, N., . . . Bredenoord, A. J. (2018). Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology, 155(4), 1022-1033.e10.
Scopus848 WoS546 Europe PMC4252017 Philpott, H., Garg, M., Tomic, D., Balasubramanian, S., & Sweis, R. (2017). Dysphagia: Thinking outside the box. World Journal of Gastroenterology, 23(38), 6942-6951.
Scopus27 Europe PMC122017 Tuck, C. J., Yao, C. K., Philpott, H. L., & Barrett, J. S. (2017). Questioning the Utility of Breath Testing in Clinical Practice. American Journal of Gastroenterology, 112(12), 1886.
Scopus1 Europe PMC12017 Philpott, H., & Thien, F. (2017). The Role of Allergy Testing in Eosinophilic Esophagitis: an Update of the Evidence.. Current treatment options in gastroenterology, 15(1), 26-34.
Europe PMC12017 Philpott, H., Kweh, B., & Thien, F. (2017). Eosinophilic esophagitis: Current understanding and evolving concepts. Asia Pacific Allergy, 7(1), 3-9.
Scopus7 Europe PMC72017 Philpott, H., & Dellon, E. S. (2017). A Penetrating Look at Eosinophilic Esophagitis Pathogenesis: Direct Antigen Exposure in the Esophagus?. Gastroenterology, 153(2), 605-606.
Scopus3 Europe PMC12017 Philpott, H., & Sweis, R. (2017). Hiatus Hernia as a Cause of Dysphagia. Current Gastroenterology Reports, 19(8), 40.
Scopus13 Europe PMC52017 Yao, C. K., Tuck, C. J., Barrett, J. S., Canale, K. E. K., Philpott, H. L., & Gibson, P. R. (2017). Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders. United European Gastroenterology Journal, 5(2), 284-292.
Scopus432016 Philpott, H., Yu, S., & Rao, S. (2016). It's All in the Mix: Diagnosis and Management of Food Intolerance. Clinical Gastroenterology and Hepatology, 14(8), 1221-1222.
Scopus2 Europe PMC22016 Philpott, H., & Gibson, P. R. (2016). Letter: dietary therapy in eosinophilic oesophagitis – do not test, just eliminate and reintroduce the most common food triggers. Authors' reply. Alimentary Pharmacology and Therapeutics, 44(8), 905-906.
Scopus1 Europe PMC12016 Philpott, H., & Gibson, P. R. (2016). Letter: avoiding misconceptions about elimination diet for eosinophilic oesophagitis – authors’ reply. Alimentary Pharmacology and Therapeutics, 44(1), 100-101.
2016 Philpott, H., Nandurkar, S., Royce, S., Thien, F., & Gibson, P. (2016). Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities. Alimentary Pharmacology and Therapeutics, 44(3), 223-233.
Scopus97 Europe PMC462016 Philpott, H., & Gibson, P. R. (2016). Editorial: Management of eosinophilic oesophagitis - Efficacy vs. effectiveness. Authors' reply. Alimentary Pharmacology and Therapeutics, 44(2), 199-200.
2016 Philpott, H., Nandurkar, S., Royce, S., Thien, F., & Gibson, P. (2016). A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis. Alimentary Pharmacology and Therapeutics, 43(9), 985-993.
Scopus70 Europe PMC442016 Philpott, H., Nandurkar, S., Royce, S. G., & Gibson, P. R. (2016). Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis. Journal of Gastroenterology and Hepatology (Australia), 31(3), 590-594.
Scopus31 Europe PMC202016 Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Editorial: gut-directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome? Authors' reply. Alimentary Pharmacology and Therapeutics, 44(8), 902-903.
2016 Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 44(5), 447-459.
Scopus125 Europe PMC582015 Yao, C. K., Barrett, J. S., Philpott, H., Chung, A. R. T., van Langenberg, D., Garg, M., & Gibson, P. R. (2015). Poor predictive value of breath hydrogen response for probiotic effects in IBS. Journal of Gastroenterology and Hepatology (Australia), 30(12), 1731-1739.
Scopus11 Europe PMC92015 Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. R. (2015). Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndRome. World Journal of Gastroenterology, 21(40), 11379-11386.
Scopus5 Europe PMC32015 Philpott, H., Nandurkar, S., Royce, S. G., & Gibson, P. R. (2015). Letter: Seasonality in eosinophilic oesophagitis and food bolus obstruction - What about recurrent episodes?. Alimentary Pharmacology and Therapeutics, 42(7), 936.
Scopus2 Europe PMC22015 Philpott, H., Nandurkar, S., Thien, F., Bloom, S., Lin, E., Goldberg, R., . . . Gibson, P. (2015). Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis. Internal Medicine Journal, 45(9), 939-943.
Scopus33 Europe PMC242015 Philpott, H., Lubel, J., & Nandurkar, S. (2015). Letter: Colestyramine for chronic unexplained diarrhoea - Promising but much to learn?. Alimentary Pharmacology and Therapeutics, 42(3), 388.
Scopus1 Europe PMC12015 Philpott, H., Royce, S., Thien, F., Nandurkar, S., & Gibson, P. (2015). What gastroenterologists should know about testing patients with eosinophilic esophagitis for food allergies. Clinical Gastroenterology and Hepatology, 13(5), 1029-1030.
Europe PMC12015 Philpott, H., Royce, S., Nandurkar, S., Thien, F., & Gibson, P. (2015). IgG and EoE: Too soon for a paradigm shift away from IgE. Gastroenterology, 148(2), 453-454.
Scopus6 Europe PMC42015 Philpott, H., Nandurkar, S., Thien, F., Gibson, P., & Royce, S. (2015). Eosinophilic esophagitis: A clinicopathological review. Pharmacology and Therapeutics, 146, 12-22.
Scopus42015 Philpott, H., Nandurkar, S., Thien, F., Gibson, P., & Royce, S. (2015). Eosinophilic esophagitis: A clinicopathological review. Pharmacology and Therapeutics, 146, 12-22.
Scopus17 Europe PMC112014 Philpott, H. L., Nandurkar, S., Lubel, J., & Gibson, P. R. (2014). Drug-induced gastrointestinal disorders. Postgraduate Medical Journal, 90(1065), 411-419.
Scopus28 Europe PMC162014 Philpott, H., Nandurkar, S., Royce, S. G., Thien, F., & Gibson, P. R. (2014). Risk factors for eosinophilic esophagitis. Clinical and Experimental Allergy, 44(8), 1012-1019.
Scopus21 Europe PMC152013 Chandran, S., Testro, A., Urquhart, P., La Nauze, R., Ong, S., Shelton, E., . . . Froomes, P. (2013). Risk stratification of upper GI bleeding with an esophageal capsule. Gastrointestinal Endoscopy, 77(6), 891-898.
Scopus22 Europe PMC82013 Sinclair, M., Roberts, S., Kemp, W., Knight, V., Dev, A., Gow, P., . . . Nicoll, A. (2013). Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria. Internal Medicine Journal, 43(5), 501-506.
Scopus7 Europe PMC42013 Philpott, H., Gibson, P. R., Thien, F., & Nandurkar, S. (2013). Letter: An allergic phenotype in patients with eosinophilic oesophagitis and asthma. Alimentary Pharmacology and Therapeutics, 37(7), 755-756.
Scopus1 Europe PMC12013 Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. R. (2013). Alternative investigations for irritable bowel syndrome. Journal of Gastroenterology and Hepatology (Australia), 28(1), 73-77.
Scopus13 Europe PMC82012 Philpott, H., Gow, P., Crowley, P., Nandurkar, S., Douglass, J., & Gibson, P. R. (2012). Systemic mastocytosis: a gastroenterological perspective.. Frontline gastroenterology, 3(1), 5-9.
2009 Shakib, S., Philpott, H., & Clark, R. (2009). What we have here is a failure to communicate! Improving communication between tertiary to primary care for chronic heart failure patients. Internal Medicine Journal, 39(9), 595-599.
Scopus11 WoS8 Europe PMC102008 Philpott, H., Kette, F., Hissaria, P., Gillis, D., & Smith, W. (2008). Chronic urticaria: the autoimmune paradigm. Internal Medicine Journal, 38(11), 852-857.
Scopus15 WoS13 Europe PMC92008 Philpott, H., Hissaria, P., Warren, L., Singhal, N., Brown, M., Proudman, S., . . . Gillis, D. (2008). Eosinophilic fasciitis as a paraneoplastic phenomenon associated with metastatic colorectal carcinoma. Australasian Journal of Dermatology, 49(1), 27-29.
Scopus18 WoS13 Europe PMC52008 Fock, K., Talley, N., Fass, R., Goh, K., Katelaris, P., Hunt, R., . . . Manatsathit, S. (2008). Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update. Journal of Gastroenterology and Hepatology, 23(1), 8-22.
Scopus157 WoS131 Europe PMC1092007 Philpott, H. L. (2007). A failure to relax. Australian Family Physician, 36(10), 849-850. 2005 Hay, P., Loukas, A., & Philpott, H. (2005). Prevalence and characteristics of men with eating disorders in primary care: how do they compare to women and what features may aid in identification?. Primary Care & Community Psychiatry, 10(1), 1-6.
Scopus18 WoS16 -
Conference Papers
Year Citation 2025 Young, E., Wan, N., Philpott, H., & Singh, R. (2025). The West Catching Up With the East: High-Magnification NBI Is Accurate for the Diagnosis of Gastric Neoplasia in a Western Population. In Journal of Gastroenterology and Hepatology (Australia) Vol. 39 (pp. 7 pages). Australia: WILEY.
DOI2018 Lee, Z. S., Tee, D., & Philpott, H. (2018). Can tissue or serum eosinophilia predict severity of Crohn's disease?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 108-109). WILEY. 2018 Philpott, H., & Dellon, E. S. (2018). Patients with eosinophilic esophagitis have a distinct immunophenotype that is detectable with food challenge, indicating esophageal food antigen presentation. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 134). WILEY. 2018 Philpott, H., & Singh, R. (2018). Endocytoscopy as an alternative to tissue biopsy to detect eosinophilic esophagitis: A novel and promising technique?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 9-10). WILEY. 2018 Philpott, H., & Dellon, E. S. (2018). CD 138 expression is increased in active eosinophilic esophagitis and not gastroesophageal reflux disease, and normalizes with treatment: Time for a new biomarker?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 133-134). WILEY. 2018 Philpott, H., & Dellon, E. S. (2018). Decreased CXCR3 expression in gastroesophageal reflux but not eosinophilic esophagitis may provide mechanistic insight. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 132-133). WILEY. 2018 Shahzad, M. A., Harding, D., Ruszkiewicz, A., Tran, E., England, G., & Philpott, H. (2018). Olmesartan-induced enteropathy: An uncommon adverse effect of a commonly prescribed drug. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 33 (pp. 173-174). WILEY. 2017 Philpott, H., & Dellon, E. S. (2017). Solid Organ Transplantation is not a Risk Factor for Eosinophilic Oesophagitis: A Review of 13,792 Transplants Performed on a Predominantly Adult Population in North Carolina. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193). Orlando, FL: NATURE PUBLISHING GROUP. 2017 Philpott, H., & Dellon, E. S. (2017). Six Weeks May Be Insufficient to Determine the Success of Elimination Diet Based on Histological Parameters Alone in Adults With Eosinophilic Esophagitis. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193). Orlando, FL: NATURE PUBLISHING GROUP. 2017 Philpott, H., Beitia, R., Barnes, C., Arrington, A., Perjar, I., Hollyfield, J., . . . Dellon, E. S. (2017). Decline in Esophageal Eosinophil Counts can be Substantial in Many Patients With Eosinophilic Esophagitis After Treatment With Proton Pump Inhibitors. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S194). Orlando, FL: NATURE PUBLISHING GROUP.
DOI2017 Philpott, H., Reed, C. C., Dougherty, M., & Dellon, E. S. (2017). Adrenal Insufficiency Is Rare With Topical Corticosteroid Treatment for Eosinophilic Esophagitis: A Systematic Review. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193-S194). Orlando, FL: NATURE PUBLISHING GROUP. -
Conference Items
Year Citation 2020 Kaazan, P., Seow, W., Tan, Z., Bednarz, J., Chung, A., Cock, C., . . . Tse, E. (2020). Deliberate foreign body swallowing in patients with underlying mental illness: A retrospective multicenter observational study. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2020 Au, M., Chan, A., Smart, C., & Philpott, H. (2020). Ustekinumab in the management of anti-tumor necrosis factor-induced psoriasiform lesions in inflammatory bowel disease: A systematic review. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2020 Chan, A., Tee, D., Rajagopalan, A., Chinnaratha, A., & Philpott, H. (2020). Targeted use of videocapsule endoscopy: Can we reduce the numbers based on symptoms or patient demographics?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2020 Chan, A., Singh, R., Ruszkiewicz, A., & Philpott, H. (2020). Eosinophilic muscularis propria of the esophagus: The cause of achalasia?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2020 Au, M., Rajagopalan, A., Tee, D., & Philpott, H. (2020). A case of checkpoint inhibitor-induced colitis with concurrent cytomegalovirus reactivation: Good response to combined antiviral and immunosuppressive therapy with infliximab. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Philpott, H., & Dellon, E. (2019). Assessment of syndecan-1 as a novel serum biomarker for monitoring eosinophilic esophagitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Lipschitz, B., Mccomish, J., & Philpott, H. (2019). Increased frequency of human leukocyte antigen DQ2 and related haplotypes in a large prospectively enrolled cohort of pediatric patients with eosinophilic esophagitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Huynh, T., Apostolov, R., Mitchell, H., O'Connor, J., Low, E., Niewiadomski, O., . . . Garg, M. (2019). The costs and outcomes of eosinophilic esophagitis in Australia: Data from a metropolitan hospital. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Chandran, V., & Philpott, H. (2019). Significant divergence in the management of esophageal reflux in Australia: Prescription of proton pump inhibitors, ordering of pH studies, and frequency of fundoplication vary markedly across the country. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Philpott, H., Hebbard, G., Garas, G., Tutticci, N., Prince, D., & Lidums, I. (2019). The number of adult gastroenterology and hepatology trainees in Australia varies between states and should be changed to meet workforce distribution constraints. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Philpott, H., Sharma, A., Rosenbaum, J., Singh, H., Rumore, S., Ellison, S., . . . Lemberg, D. (2019). Rapid increase in the prevalence of eosinophilic esophagitis among Australasian children: A decade of experience from six capital cities. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
WoS1
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2022 Co-Supervisor Advances in the endoscopic diagnosis and treatment of gastrointestinal neoplasia Doctor of Philosophy Doctorate Part Time Mr Edward John Young
Connect With Me
External Profiles